A78-year-old woman on prophylactic subcutaneousuow molecular weightheparin7daysafter hip-
replacementsurgery developsalargeerythematousraised areaaroundtheheparin injection site inher right
arm.Thefollowinqdaythishasenarged.has ablacknecrotic centre.andafuu bloodcount checkrevealsa
plateletcount ofonl 33.Furthertestsshowapositive antibodytestfor plateletfactor4-heparincomple>
antibodies.whichconfirmsthediaqnosisofheparin-induced thrombocytopeniatype
Whichoneofthefouowinaisthemostappropriatenextuineofmanagement?
Changetoan alternativeform oflow molecular weight heparin
Stopheparinandcommenceanon-heparinoidbased anticoagulant
Stopheparinand commence warfarin
Stopheparinandobserve
Stopuowmolecularweightheparinand maintain onanunfractionatedheparin infusion
@1MINENDOCRINE
